Market Overview

UPDATE: Deutsche Bank Downgrades HealthSouth Corporation to Hold; Valuation Full

Share:
Related HLS
Benzinga's Top Upgrades, Downgrades For February 14, 2017
Companies That Have The Most To Lose If Obamacare Is Repealed

Deutsche Bank downgraded HealthSouth Corporation (NYSE: HLS) from Buy to Hold and lowered the price target from $28.50 to $25.00.

Deutsche Bank commented, "HLS' revenue growth prospects remain underpinned by good organic volume trends, acceleration of de novos and JV/M&A opportunities. Despite our favorable view for "HLS the company," we see a more balanced risk/reward for "HLS the stock," with the potential for Medicare pressure over the next 12-24 months the key gaiting factor for HLS' valuation multiple. Hold more accurately reflects our stance on HLS shares."

HealthSouth Corporation closed at $23.86 on Thursday.

Latest Ratings for HLS

DateFirmActionFromTo
Feb 2017Craig-HallumInitiates Coverage OnBuy
Feb 2017Craig-HallumInitiates Coverage OnBuy
Jan 2017PiperJaffrayInitiates Coverage OnNeutral

View More Analyst Ratings for HLS
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Downgrades Analyst Ratings

 

Related Articles (HLS)

View Comments and Join the Discussion!